Form D · Pharmaceuticals
MEDITRINA PHARMACEITICALS INC
Ann Arbor, MI · CIK 0001433193
Offering snapshot reported Dec 28, 2010 · SEC filing
- Reported sold
- $50K Offering amount: $500K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Dec 16, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 28, 2010 | Initial | $50,000 | No comparison | 1 | SEC filing |
| Dec 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 21, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-152558
Source: Form D, filed Dec 28, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Collet | Director, Executive |
| Robert Whitehead | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
300 North Fifth Avenue Suite 150
Ann Arbor, MI, 48104
Ann Arbor, MI, 48104